Document is current

Any future updates will be listed below

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study

Crossref DOI link: https://doi.org/10.1186/s12885-015-1673-3

Published Online: 2015-10-08

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark